ClinConnect ClinConnect Logo
Search / Trial NCT06560255

Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma

Launched by PROFESSOR KLAUS BØNNELYKKE · Aug 15, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Childhood Asthma Infections Eczema Allergy Development Psychiatry Bone Development Cognition Growth

ClinConnect Summary

This clinical trial is studying whether taking fish oil supplements during pregnancy can help prevent asthma and breathing problems in young children. Researchers believe that giving higher doses of fish oil than usually recommended might reduce the chances of children developing asthma or wheezing issues in their first three years of life. They are currently looking for pregnant women in Denmark who are less than 26 weeks along, have low levels of certain fatty acids in their blood, and do not plan to take fish oil supplements during their pregnancy.

If you qualify and decide to participate, you will receive fish oil supplements to take during your pregnancy. The study aims to see if this nutritional approach can make a difference in the health of your child, particularly regarding respiratory and allergy-related issues. It is important to know that this trial is specifically for women who have no serious health conditions related to their hormones, heart, or kidneys. Your involvement could help researchers learn more about how diet during pregnancy might protect children from developing asthma and other related conditions.

Gender

FEMALE

Eligibility criteria

  • Pregnant Danish women before week 26 with blood levels of EPA+DHA below 4.7% of total fatty acids
  • No planned use of fish oil supplementations
  • No endocrine-, heart-, kidney- or auto-immune disorders

About Professor Klaus Bønnelykke

Professor Klaus Bønnelykke is a distinguished clinical trial sponsor known for his expertise in respiratory medicine and pediatric allergies. With a strong academic background and extensive experience in clinical research, he leads innovative studies aimed at advancing understanding and treatment of respiratory conditions in children. Professor Bønnelykke is committed to fostering collaboration between academic institutions and healthcare stakeholders, ensuring that research findings translate effectively into clinical practice. His dedication to improving patient outcomes is reflected in his rigorous approach to trial design and execution, making him a respected figure in the field of clinical research.

Locations

Gentofte, , Denmark

Patients applied

0 patients applied

Trial Officials

Bo Chawes, PhD

Principal Investigator

Copenhagen Studies on Asthma in Childhood

Klaus Bønnelykke, PhD

Principal Investigator

Copenhagen Studies on Asthma in Childhood

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported